PROVIDER PROFILE · NPI 1093117079

Inessa ArtsrunyanNP

PRACTICEVERDUGO HILLS HOSPITALSee all providers at this practice →

Nurse PractitionerGlendale, CAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

575

Unique beneficiaries

—

Total services

589

Distinct HCPCS

Medicare payment

$51K

Peer benchmark

Total Medicare services vs. 8,685 Nurse Practitioner providers in CA — near median (cohort median 222).

PRESCRIBING · PART D · 2024

Total Rx claims

107

Beneficiaries

—

Total drug cost

$949

Distinct drugs

Brand share

41.1%

Top prescribed drugs

Cephalexin30 claims

Sulfamethoxazole/Trimethoprim22 claims

Doxycycline Hyclate18 claims

Cefdinir15 claims

Amoxicillin/Potassium Clav11 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$91

Payment records

By payment type

Food and Beverage$91

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 050124

Hospital

REFERRAL NETWORK

Where Inessa Artsrunyan's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Razmik Ohanjanian Internal Medicine · Glendale, CA	34	153
Kaveh Soleimanpour Diagnostic Radiology · Los Angeles, CA	12	41

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Razmik Ohanjanian Internal Medicine · Glendale, CA	44	251
Linh Chen Diagnostic Radiology · Glendale, CA	15	38
GLENDALE ADVENTIST MEDICAL CENTER	14	40

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history